China approved third Covid-19 vaccine for clinical trials

The Chinese authorities approved for clinical trials of the third vaccine from coronavirus, developed by the National Pharmaceutical Company SINOPHARM.

As the TASS reports, this is stated in an official statement published on Saturday on its Weibo social network page.

“This is a recombinant vaccine containing coronavirus spit-shaped protein elements,” is specified in it. According to the application, the new drug “has reinforced properties to stimulate the immune protection of the body.”

According to official data, in addition to the mentioned new items, more than five more drugs from Coronavirus have been developed in China: three inactivated, adenovirus and recombinant protein. They are designed for vaccination in one, two or three stages.